South & Central America Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type, Condition, and End User

Description

List of Tables

The South & Central America hyperpigmentation disorder treatment market was valued at US$ 887.76 million in 2022 and is expected to reach US$ 1,484.28 million by 2030; it is estimated to register a CAGR of 6.6% from 2022 to 2030.

Rise in Prevalence of Melasma Fuels South & Central America Hyperpigmentation Disorder Treatment Market

Melasma, one of the most dominant hyperpigmentation conditions, is characterized by symmetrical light to dark muddy-brown macules with borders on the face, particularly the chin, upper lip, nose, forehead, and cheeks. It is prevalent among women and those with darker complexion. Malar, mandibular, and centrofacial clinical features are common in melasma. Sun exposure, hormonal variations, pregnancy, hereditary factors, cosmetics, and medicines have all been linked to the development of melasma. Various studies have estimated that the overall prevalence of melasma in the general population ranges from 1% to 50%. 55-64% of melasma cases have reported a family history of the same condition.

Pregnancy is another common cause of melasma. This condition also impacts women taking oral contraceptives and hormones. Estrogen, progesterone, and melanocyte-stimulating hormone levels normally rise during the third trimester of pregnancy, which may be a factor. According to the National Center for Biotechnology Information (NCBI) in August 2023, melasma is more common in reproductive years, and it rarely occurs before puberty; the condition occurs in 15-50% of pregnant women, and its prevalence ranges from 1.5% to 33%, depending on the population in a different region. Therefore, an upsurge in melasma prevalence triggers the demand for hyperpigmentation treatments.

South & Central America Hyperpigmentation Disorder Treatment Market Overview

The hyperpigmentation disorder treatment market in Brazil is experiencing notable growth due to the rising number of hyperpigmentation cases. According to an article published by the Journal of Skin and Stem Cell in January 2022, the prevalence of pigmented phenotypes is higher in Southeast Asian, Middle Eastern, Mediterranean, Hispanic-American, and Brazilian populations. A study based in Brazil presented in the article concluded that melasma was the third most frequent reason for skin-related consultations among 57,343 patients.

Furthermore, with the expansion of healthcare expenditure in Brazil, there is a corresponding rise in investments and resources allocated to dermatological care, including product development activities and the promotion of effective acne medications. This financial boost enhances research and development efforts, fostering the introduction of advanced formulations and treatment options in the market in the country. The improved accessibility to healthcare services and growing skincare awareness further bolsters the demand for hyperpigmentation disorder treatment across the country.

South & Central America Hyperpigmentation Disorder Treatment Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Hyperpigmentation Disorder Treatment Market Segmentation

The South & Central America hyperpigmentation disorder treatment market is categorized into treatment type, condition, end user, and country.

By treatment type, the South & Central America hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest share of the South & Central America hyperpigmentation disorder treatment market share in 2023.

In terms of condition, the South & Central America hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest share of the South & Central America hyperpigmentation disorder treatment market share in 2023.

By end user, the South & Central America hyperpigmentation disorder treatment market is hospitals, dermatology centers, and others. The hospital segment held the largest share of the South & Central America hyperpigmentation disorder treatment market share in 2023.

Based on country, the South & Central America hyperpigmentation disorder treatment market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil segment held the largest share of South & Central America hyperpigmentation disorder treatment market in 2023.

AbbVie Inc, Bayer AG, Galderma SA, L'OREAL S.A., Lutronic Co Ltd, Obagi Cosmeceuticals LLC, and Pierre Fabre SA are some of the leading companies operating in the South & Central America hyperpigmentation disorder treatment market.

Product Code: BMIRE00031386

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Melasma
- 4.1.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
4.2 Market Restraints
- 4.2.1 High Cost of Treatments
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Use of Ablative Lasers
- 4.4.2 Novel Products Based on PATH-3 Technology
4.5 Impact of Drivers and Restraints:

5. Hyperpigmentation Disorder Treatment Market - South & Central America Analysis

5.1 South & Central America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030

6. South & Central America Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type

6.1 Cosmeceutical
- 6.1.1 Overview
- 6.1.2 Cosmeceutical: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Light or Laser Therapy
- 6.2.1 Overview
- 6.2.2 Light or Laser Therapy: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Microdermabrasion
- 6.3.1 Overview
- 6.3.2 Microdermabrasion: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Chemical Peels
- 6.4.1 Overview
- 6.4.2 Chemical Peels: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cryotherapy
- 6.5.1 Overview
- 6.5.2 Cryotherapy: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Hyperpigmentation Disorder Treatment Market Analysis - by Condition

7.1 Melasma
- 7.1.1 Overview
- 7.1.2 Melasma: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Solar Lentigines
- 7.2.1 Overview
- 7.2.2 Solar Lentigines: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Post-inflammatory Hyperpigmentation
- 7.3.1 Overview
- 7.3.2 Post-inflammatory Hyperpigmentation: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Hyperpigmentation Disorder Treatment Market Analysis - by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Dermatology Centers
- 8.2.1 Overview
- 8.2.2 Dermatology Centers: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Hyperpigmentation Disorder Treatment Market - Country Analysis

9.1 South & Central America Hyperpigmentation Disorder Treatment Market Overview
- 9.1.1 South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 South & Central America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 Brazil
  - 9.1.1.3 Brazil: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.3.1 Brazil: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.3.2 Brazil: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.3.3 Brazil: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.4 Argentina
  - 9.1.1.5 Argentina: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.5.1 Argentina: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.5.2 Argentina: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.5.3 Argentina: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.6 Rest of South & Central America
  - 9.1.1.7 Rest of South & Central America: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.7.1 Rest of South & Central America: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.7.2 Rest of South & Central America: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.7.3 Rest of South & Central America: Hyperpigmentation Disorder Treatment Market Breakdown, by End User

10. Hyperpigmentation Disorder Treatment Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
10.3 Organic Growth Strategies
- 10.3.1 Overview
10.4 Inorganic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 AbbVie Inc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Galderma SA
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Obagi Cosmeceuticals LLC
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Bayer AG
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Lutronic Co Ltd
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 L'OREAL S.A.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Pierre Fabre SA
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms